Clinical Trials Directory

Trials / Unknown

UnknownNCT04533009

Tramadol-paracetamol Combination in Treatment of Patients Undergoing Spinal Surgery

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Kuopio University Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Tramadol-paracetamol combination is studied in patients coming for elective spine surgery. The study drug is started at the day of surgery and continued maximum of five days. Before the surgery pain, use of pain medication, satisfaction for pain medication, adverse effects, resilience, depression and life satisfaction were asked. At the discharge and seven days after the surgery use of pain medication and adverse effects were asked. The patients were followed up to 28 days and one year after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDUREspine surgeryTramadol-paracetamol 325mg/37,5mg two tablets twice daily

Timeline

Start date
2020-02-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2020-08-31
Last updated
2023-10-26

Locations

1 site across 1 country: Finland

Source: ClinicalTrials.gov record NCT04533009. Inclusion in this directory is not an endorsement.

Tramadol-paracetamol Combination in Treatment of Patients Undergoing Spinal Surgery (NCT04533009) · Clinical Trials Directory